Source: Citybizlist

PreciseDx: PreciseDx Announces Formation of Scientific Advisory Board

PreciseDx, a leading innovator in AI-powered digital pathology focused on oncology diagnostics, today announced the formation of its Scientific Advisory... Read MoreThe post PreciseDx Announces Formation of Scientific Advisory Board appeared first on citybiz.

Read full article »

PreciseDx's Competitors | PreciseDx's News | PreciseDx's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Wayne Brinster

CEO Approval Rating

90/100

PreciseDx is a New York-based AI platform that provides solutions such as cancer risk stratification and personalized treatment analytics for the healthcare industry.